Admission Date:  [**2101-1-1**]              Discharge Date:   [**2101-1-29**]  Date of Birth:  [**2035-8-12**]             Sex:   F  Service: MEDICINE  Allergies: Penicillins / Demerol / Iodine / Latex / Betadine  Attending:[**First Name3 (LF) 30**] Chief Complaint: bilateral lower extremity weakness x 6 weeks.
Epidural catheter placement.
Right internal jugular central catheter placement, subsequently removed.
No medications were given.
MRI Brain: diffuse perivascular changes c/w chronic ischemic changes vs MS [**First Name (Titles) **] [**Last Name (Titles) **]   Past Medical History: HTN COPD Osteopenia CRI (baseline Cr 1.6) PVD: s/p aortobifem [**2091**] and [**2095**], s/p right SFA and [**Doctor Last Name **] angio, s/p right SFA stenting, s/p a right common iliac to left renal artery bypass, s/p right renal artery stenting, s/p right profunda femoris to posterior tibial bypass AAA repair with stenting Hypercholesterolemia   Social History: Former heavy smoker.
Physical Exam: VS: 98.3 140/59 80 20 94RA Gen: NAD, AAOx3, lying flat in bed HEENT: NC/AT, PERRLA, mmm NECK: no LAD, no JVD, no carotid bruit COR: S1S2, regular rhythm, no m/r/g PULM: CTA b/l, no wheezing or rhonchi ABD: + bowel sounds, soft, nd, nt Skin: warm extremities, no rash EXT: 2+ DP, no edema/c/c, no CVA tenderness Neuro: moving all extremities, 3/5 strength in HF, KE [**3-24**], arms [**4-23**] following commands, PERRLA, CN2-12 intact, except for ptosis R eye, double vision in all directions, reflexes absent b/l, babinsky upgoing b/l, cerebellar sign not tested  Pertinent Results: [**2101-1-1**] 12:15AM   PT-10.9 PTT-21.8* INR(PT)-0.9 [**2101-1-1**] 12:15AM   PLT COUNT-385 [**2101-1-1**] 12:15AM   NEUTS-72.1* LYMPHS-20.9 MONOS-4.8 EOS-1.8 BASOS-0.4 [**2101-1-1**] 12:15AM   WBC-12.5* RBC-4.42# HGB-13.5# HCT-38.2# MCV-87 MCH-30.6 MCHC-35.3* RDW-13.7 [**2101-1-1**] 12:15AM   CALCIUM-10.4* PHOSPHATE-4.4 MAGNESIUM-2.4 [**2101-1-1**] 12:15AM   estGFR-Using this [**2101-1-1**] 12:15AM   GLUCOSE-99 UREA N-18 CREAT-1.3* SODIUM-138 POTASSIUM-3.8 CHLORIDE-100 TOTAL CO2-26 ANION GAP-16 [**2101-1-1**] 04:10PM   PTH-70* Micro:URINE CULTURE (Final [**2101-1-4**]):       ENTEROCOCCUS SP..    >100,000 ORGANISMS/ML..                                SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              ENTEROCOCCUS SP.
Large prevascular and pretracheal lymph nodes, concerning for malignancy as described above.
[**2101-1-7**] BONE SCAN 1.
Following intravenous contrast administration, no abnormal enhancement is noted.
Note:  Immunohistochemical studies for keratin AE1/AE1, CAM 5.2, and chromogranin show focal immunoreactivity.
Cell marker analysis was performed but was non-contributory in this case due to insufficient number of lymphoid cells for analysis.
There are bilateral spinal rods and a right IJ line as well as skin staples.
Metallic densities overlie two disc levels in the mid thoracic spine.
Vertebral body heights are preserved throughout the cervical, thoracic, and lumbar spine.
If this does not represent a bone graft donor site, then further evaluation for bony lesion would be recommended.
[**2101-1-25**] PET-CT 1.
Extensive mediastinal lymphadenopathy with focal abnormal uptake of FDG with a 2.3 cm prevascular node with SUV of 15, and a 1 cm precarinal node with SUV 16.
Brief Hospital Course: Mrs. [**Known lastname 7046**] is a 65 year old woman with a history of PVD, HTN and CKD who presented with bilateral lower extremity weakness and numbness for six weeks.
She was started on dexamethasone which should be tapered after completion of XRT.
DVT prophylaxis was provided with lovenox and should be continued after discharge.
The patient was instructed to continue using the patch after discharge.
A heparin drip was initiated then stopped because the clot was in a superficial vein.
PTHRP was normal, but vitamin D was low.
Because her calcium normalized, no further work-up or intervention was pursued.
Vitamin D supplementation was initiated.
It was treated with aspirin, clopidogrel and a statin.
She required 2 units of PRBCs after which her hematocrit responded appropriately and was stable for the remainder of her stay.
She was continued on a statin, beta-blocker, aspirin and clopidogrel.
HTN: The patient has a history of hypertension and was well controlled on this admission with amlodipine and a beta-blocker.
Medications on Admission: Amlodipine 5 mg once daily Plavix 75 mg daily Lovastatin 10 mg daily Percocet prn Aspirin 325 mg daily Metoprolol tartrate 100 mg twice a day Lasix 20 mg prn daily  Discharge Medications: 1.
Amlodipine 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily): this is your plavix.
Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 50 mg Tablet Sig: 2.5 Tablets PO BID (2 times a day).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Enoxaparin 40 mg/0.4 mL Syringe Sig: One (1)  Subcutaneous QD ().
Lactulose 10 g/15 mL Syrup Sig: Thirty (30) ML PO TID (3 times a day).
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical TID (3 times a day).
Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID (4 times a day) as needed for thrush.
Oxycodone 5 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed.
OxyContin 10 mg Tablet Sustained Release 12HR Sig: Three (3) Tablet Sustained Release 12HR PO every twelve (12) hours: Administer with 40 mg tablet for a total of 70mg q 12 hours.
OxyContin 40 mg Tablet Sustained Release 12HR Sig: One (1) Tablet Sustained Release 12HR PO every twelve (12) hours: Administer with three 10 mg tablets of oxycontin for total dose of 70mg q12h.
Dexamethasone 4 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
CAD s/p RCA Stent ([**Hospital1 336**]) 9.
S/P Aortobifemoral Bypass Graft 2.
RLE SFA Stenosis s/p unsuccessful PCI 3.
Right arm fasciotomy/grafting (iatrogenic compartment syndrome)   Discharge Condition: stable, afebrile, tolerating po   Discharge Instructions: You presented to the hospital with lower extremity weakness and you were found to have a mass in your thoracic spine.
You also underwent an operation for T3 to T11 vertebral fusion.
You will require radiation therapy and chemotherapy for your cancer.
Please take all medications as prescribed.
You should wear an eye patch and alternate between eyes every 3 to 4 hours.
